The Mind-Body Tug-of-War: Untangling Psychological vs. Physical Drug Dependence

Contributors

Dr. Narayanan Mooss

Ayurvedic Psychiatrist

Ms. Muktha

Clinical Psychologist

Key Take Aways

Drug addiction, clinically known as Substance Use Disorder (SUD), is a chronic brain-based condition involving compulsive substance use despite harmful consequences, while physical dependence refers specifically to the body’s adaptation and withdrawal response to a drug. Addiction affects the brain’s reward, stress, and decision-making systems, making cravings and relapse neurological processes rather than simple choices, and co-occurring mental health conditions often intensify both physical and psychological dependence. Evidence-based treatments such as medically supervised detox, Medication-Assisted Treatment (MAT), CBT, DBT, Motivational Interviewing, and long-term recovery support significantly improve outcomes and reduce overdose risk. Ayurveda views addiction as a doshic imbalance and depletion of Ojas, supporting recovery with Panchakarma, grounding therapies, and Medhya Rasayana herbs like Ashwagandha and Brahmi under professional guidance, while yoga, pranayama, mindfulness, and meditation help regulate the nervous system, reduce stress, and strengthen emotional self-regulation. Recovery typically requires sustained, multi-dimensional support, but meaningful healing and long-term stability are entirely possible.

Full Article

Understanding the intricate dance between your mind and body in chronic drug addiction is the first step towards lasting recovery.

For instance, you might wonder:

All of these questions are normal and it’s understandable that you want to support your loved one to the best of your ability

While your questions are valid, it’s also important to understand that every person’s experience with depression is unique, so there are a few things you can do to help your loved one and yourself.

Introduction: The Two Faces of Addiction

Most people think of addiction as a single thing – a habit gone wrong, a matter of willpower, or a body hooked on a substance. The reality is considerably more complicated, and understanding that complexity is what separates treatment that works from treatment that keeps failing.

Drug addiction is formally classified in the DSM-5 under Substance Use Disorder – a spectrum condition characterised by a problematic pattern of drug use leading to clinically significant impairment or distress. Crucially, addiction is not a single diagnosis but sits across a continuum from mild to moderate to severe, defined by how many of eleven diagnostic criteria are met: impaired control over use, social impairment, risky use, and pharmacological criteria including tolerance and withdrawal.

Within that clinical picture, two distinct but deeply intertwined processes are at work: physical dependence and psychological dependence. Disentangling them is not merely academic. It is the practical foundation of effective treatment – because the physical and psychological dimensions of addiction respond to different interventions, have different timelines, and create very different challenges for the person in recovery.

Physical dependence is what happens to the body when it has adapted to the presence of a drug and now requires it to function normally. Psychological dependence is what happens to the mind: the cravings, the compulsions, the emotional reliance, the sense that using is the only way to cope. Most people in chronic addiction are dealing with both at the same time, each one amplifying the other in a cycle that takes real clinical effort to break.

This article maps both faces of addiction – the neurobiology behind them, how they interact, what evidence-based treatment looks like for each, and how Eastern frameworks (Ayurveda and Yoga) complement Western clinical care in supporting recovery.

Important language note: The term ‘substance abuse’ is increasingly avoided in clinical settings because it carries moral judgment that adds to the stigma which stops people from seeking help. NIDA and SAMHSA now prefer ‘substance use disorder’ or ‘substance misuse.’ Throughout this article we use clinical language that centres the person in recovery, not the addiction.

"Recovery is not a destination. It is a process."

What Is Physical Dependence?

Physical dependence is the body’s neurobiological adaptation to chronic drug exposure. It is not the same as addiction – you can be physically dependent on a medication without being addicted to it – but in chronic drug addiction, the two almost always co-exist.

Here is what is happening at the level of the brain and nervous system when physical dependence develops:

The Neurobiology: How the Brain Adapts

Every addictive drug – opioids, stimulants, alcohol, cannabis, nicotine, benzodiazepines – works by flooding the brain’s reward circuit with dopamine, or by mimicking or amplifying the effects of neurotransmitters that naturally activate it. The key structures are the Ventral Tegmental Area (VTA), which produces dopamine; the Nucleus Accumbens (NAc), the brain’s primary reward centre, where dopamine produces its reinforcing effects; and the Prefrontal Cortex (PFC), responsible for decision-making, impulse control, and rational evaluation of consequences.

When drugs flood the NAc with dopamine – at levels that can be ten times the amount produced by natural rewards like food or sex – the brain experiences this as an intense signal of reward. With repeated exposure, the brain adapts in ways that attempt to re-establish equilibrium. The most consequential adaptation is downregulation: the brain reduces the number and sensitivity of dopamine D2 receptors in the reward circuitry. This has two compounding effects: the drug starts producing less pleasure (tolerance, requiring more drug to achieve the same effect), and natural rewards – food, relationships, exercise, accomplishment – also produce less pleasure, because they depend on the same now-depleted dopamine system.

Simultaneously, the extended amygdala – the brain’s stress system – becomes recruited. This is where the CRF (corticotropin-releasing factor), norepinephrine, and dynorphin systems become increasingly active. These systems are associated with negative emotional states: anxiety, irritability, dysphoria. Over time, drug use transitions from being about getting high to being about avoiding withdrawal – using not for pleasure but to feel normal, to stave off the distress of the brain’s stress systems operating without the drug’s modulation.

The Body's Rebellion: Withdrawal Symptoms

When drug use stops after physical dependence has developed, the body’s adapted state becomes suddenly visible. The nervous system, calibrated to function in the presence of the drug, now overcorrects in its absence. Withdrawal symptoms vary dramatically by drug class:

Opioids: Opioid withdrawal is intensely physically distressing - severe muscle aches, sweating, vomiting, diarrhoea, insomnia, goosebumps, and unbearable restlessness (akathisia). It is rarely life-threatening but feels, to those experiencing it, like it might be. The discomfort peaks at 36-72 hours for short-acting opioids and can last days to weeks.
Alcohol: Among the most dangerous withdrawal syndromes. Alcohol acts on GABA receptors (the brain's primary inhibitory system); chronic use suppresses GABA and upregulates glutamate (the primary excitatory system). When alcohol is removed, the suppressed inhibitory system is temporarily overwhelmed by the hyperactive excitatory system. This produces tremors, sweating, anxiety, insomnia, and in severe cases - seizures and delirium tremens (DTs), which can be fatal without medical management.
Benzodiazepines: Produces significant physical withdrawal - anxiety, insomnia, rebound hypertension, heart palpitations, and in heavy/long-term users, potentially dangerous seizures. Medical supervision during benzodiazepine detox is strongly recommended.
Stimulants (cocaine, methamphetamine): Physical withdrawal is less dangerous than opioids or alcohol but deeply uncomfortable - fatigue, depression, increased appetite, hypersomnia, dysphoria. The psychological craving component is often more clinically significant than the physical symptoms.

Medical detox is not optional for opioid, alcohol, and benzodiazepine dependence.Withdrawal from these substances can be medically dangerous and is far more likely to succeed with supervised medical management. Attempting to detox from alcohol or benzodiazepines without medical supervision carries real risk of seizures. Always involve a healthcare professional in the detox process.

What Is Psychological Dependence?

If physical dependence lives in the body’s cellular and neurochemical adaptations, psychological dependence lives in the mind’s learnt associations, beliefs, coping patterns, and emotional architecture. And in many ways, it is the harder of the two to treat – because while physical withdrawal resolves within days to weeks, the psychological dimensions of addiction can persist for months, years, or for the rest of a person’s life if not actively addressed.

Understanding psychological dependence means understanding how addiction reprogrammes the brain’s learning systems, not just its reward chemistry.

Cravings, Compulsions, and the Mental Maze

Cravings – the intense, urgent desire to use – are the most viscerally experienced feature of psychological dependence. But cravings are not simply a desire for pleasure. At a neurobiological level, they reflect a phenomenon researchers call incentive salience: the drug-associated cues that predicted drug delivery have become abnormally powerful motivational magnets. The nucleus accumbens and amygdala – which encode reward prediction and emotional memory respectively – have been rewired by chronic drug use to treat drug-associated stimuli as the most biologically significant things in the environment.

This means that a craving is not consciously chosen. It is, at its root, a conditioned neurological response – as automatic as the salivation response to the smell of food, except that it can be triggered by highly specific cues (a particular street, a person’s face, a sound, a smell, an emotional state) and can produce consuming, overwhelming urgency. Research documents an ‘incubation of craving’ phenomenon in which cravings actually increase in intensity over the first weeks to months of abstinence, even as physical withdrawal resolves – because the mesolimbic circuits encoding drug associations are being progressively consolidated rather than extinguished.

The compulsive quality of psychological dependence – continuing to use despite wanting to stop, despite clear consequences, despite genuine intention – reflects the chronic downregulation of prefrontal cortex activity in addicted individuals. The PFC is responsible for evaluating long-term consequences, overriding impulses, and making decisions based on future outcomes rather than immediate reward. With chronic addiction, PFC control is weakened. The result is that the addicted person is not simply choosing to use over not using; they are operating with impaired capacity for the rational override that would support the choice to stop.

Triggers: The Mind's Achilles Heel

Triggers are the specific cues – internal or external – that activate the craving response. Understanding a person’s trigger landscape is foundational to relapse prevention. They fall into several categories:

Environmental and situational triggers: People the person used with, places where they used, objects associated with use (e.g. needles, pipes, particular rooms), or situational contexts (e.g. a specific time of day, a route home, a neighbourhood).
Stress and negative emotion: Stress is one of the most reliably documented triggers for craving and relapse, because the same CRF-mediated stress systems implicated in withdrawal are also activated by external stressors. The addicted brain has learnt that the drug relieves stress - making stress itself a powerful drug-seeking cue.
Emotional states: For many people in recovery, specific emotions - loneliness, shame, boredom, anxiety, anger, grief - are the most potent triggers. These are often the very emotional states that drug use was originally a response to, particularly when there is a history of trauma or untreated mental health conditions.
Positive emotional states: Paradoxically, positive emotional states - celebration, feeling confident, being around old friends in a good mood - can also trigger use through associative memory (this situation previously involved drugs).

Psychological dependence outlasts physical withdrawal. This is why the common expectation that ‘drying out’ for a week or two should fix addiction is so dangerous. Physical detox is the beginning of recovery, not the end of it. The psychological rewiring of addiction – the cravings, the triggers, the impaired self-regulation, the emotional vulnerabilities – requires months of sustained therapeutic work to address. Relapse after short-term detox without ongoing psychological treatment is the rule rather than the exception.

The Interplay: When Body and Mind Collide

Physical and psychological dependence are not parallel processes running independently – they are deeply intertwined feedback loops, each one amplifying and sustaining the other.

Consider what happens during the acute withdrawal phase. The physical symptoms – sweating, nausea, muscle pain, insomnia – are directly distressing, but they also generate intense psychological distress. The person in early withdrawal is not just physically uncomfortable; they are experiencing the full activation of the brain’s stress and alarm systems without the buffer the drug used to provide. Anxiety, dysphoria, terror, and a profound sense of ill-being combine with the physical symptoms to produce an overall state that the brain processes as: using would fix this immediately. The craving this generates is not a preference or a desire – it is an emergency signal from a brain system that has learnt to interpret drug absence as existential threat.

Moving further into recovery, physical withdrawal resolves – but the psychological dimensions intensify in certain respects. The incubation of craving phenomenon means that weeks into abstinence, encounters with triggers can produce cravings at least as intense as those in early withdrawal. The person may have detoxed physically while still operating within a brain that has been comprehensively rewired by addiction – with weakened PFC control, hyperactive stress reactivity, blunted natural reward responses, and deeply consolidated drug-associated memories that can be reactivated at any time.

There is also the emotional layer. Many people who develop addiction have pre-existing mental health conditions – depression, anxiety, PTSD, ADHD – that drug use was providing partial relief for. When the drug is removed, those conditions re-emerge, often acutely. The distress created by unaddressed co-occurring mental health conditions is itself a powerful driver back to use. NIDA estimates that more than half of people with a substance use disorder have at least one co-occurring mental health condition, and treatment that does not address both simultaneously is substantially less effective than integrated care.

This is the full picture of chronic addiction: a neurobiological rewiring that affects reward, motivation, stress reactivity, and decision-making; layered over a psychological landscape of triggers, emotional vulnerabilities, and learnt coping patterns; often co-occurring with mental health conditions that were there before the addiction started. Recovery requires holding all of this at once.

A Holistic View: Integrating Western and Eastern Perspectives

Western Psychiatry and Neuroscience

Western medicine approaches addiction through a biopsychosocial lens, treating it as a chronic brain disease with neurobiological underpinnings, psychological drivers, and social determinants. This framework has yielded some of the most effective treatments for substance use disorder in history, including Medication-Assisted Treatment (MAT) for opioid and alcohol use disorders – which NIDA describes as the most effective treatment for opioid use disorder, reducing the likelihood of overdose death by up to three-fold.

The Western clinical approach recognises that addiction involves three distinct brain circuits that require three different levels of intervention: the reward/reinforcement circuits (addressed by medication and behavioural activation); the stress/negative affect circuits (addressed by therapy, stress management, and treating co-occurring mental health conditions); and the prefrontal/inhibitory control circuits (addressed by CBT, contingency management, and structured recovery support that builds the executive function skills that addiction has eroded).

Ayurveda: Balancing the Doshas for Recovery

Ayurveda classifies addiction under the heading of Madatyaya – the state arising from the continuous use of intoxicating substances. It views this not as a moral failure but as a profound disturbance of the body’s doshic balance, the Manovaha Srotas (channels of mental functioning), and the depletion of Ojas – the vital essence that provides emotional resilience, mental stability, and the will to resist compulsion.

The three doshic patterns relevant to addiction are:

Vata (air and ether): Excess Vata produces the restlessness, anxiety, insomnia, racing thoughts, and emotional volatility that characterise early withdrawal and the hyperactive stress-response state of early recovery. Vata-dominant addiction presentations often involve stimulants, cannabis, or anxiolytic substances used to manage the nervous system's overactivity.
Pitta (fire and water): Excess Pitta generates the irritability, explosive anger, intense craving, and the burning dissatisfaction that drives many people to use substances to relieve emotional heat. Pitta-type presentations often involve substances used to regulate emotional intensity.
Kapha (earth and water): Excess Kapha produces the heaviness, apathy, withdrawal, inability to get started, and the dulling of motivation that characterises the depressive phase of addiction and protracted abstinence syndrome. Kapha-dominant presentations often involve substances used to manage low mood, low energy, or anhedonia.

The Ayurvedic framework adds a dimension Western neuroscience is now beginning to formally acknowledge: that the emotional layer of addiction – the shame, the fractured sense of self, the spiritual disconnection – requires healing at a level that goes beyond receptor pharmacology. The Sattvajaya Chikitsa (mind-purification therapy), Rasayana (rejuvenation and rebuilding), and the Dinacharya (structured daily routine) of Ayurveda address the recovery of Ojas – the vital resilience that enables a person to face stress, cravings, and emotional pain without being overwhelmed by them.

Panchakarma: Deep Detoxification

Panchakarma – Ayurveda’s five-action detoxification therapy – is used in Ayurvedic addiction treatment to systematically eliminate the Ama (metabolic toxins) accumulated from drug use, restore doshic balance, and prepare the body and nervous system for healing. Key Panchakarma procedures used in addiction recovery include:

Virechana (therapeutic purgation): detoxifies the liver and colon - both heavily stressed by substance use - and reduces Pitta-associated emotional heat and irritability.
Basti (medicated enema): deeply nourishes and grounds the Vata-disturbed nervous system, addressing the restlessness, insomnia, and anxiety of withdrawal and early recovery.
Shirodhara (continuous warm oil flow on the forehead): directly calms the central nervous system, reduces cortisol, changes the EEG pattern to a more relaxed state, and supports sleep. Extensively documented in clinical use for anxiety, insomnia, and stress-related nervous system disorders.
Abhyanga (full-body warm oil massage): counters Vata depletion, nourishes the nervous system, promotes vasodilation and relaxation, and creates a physical experience of safety and comfort that directly supports the parasympathetic recovery that addiction's chronic stress activation has disrupted.

Ayurvedic Herbal Support for Recovery

Key Medhya Rasayana herbs used in Ayurvedic addiction recovery protocols:

Ashwagandha (Withania somnifera): The premier adaptogen for stress system recovery. Ashwagandha reduces cortisol, supports HPA axis rebalancing, reduces anxiety and withdrawal-related distress, and promotes neurogenesis. A double-blind PMC RCT documented 27.9% cortisol reduction over 60 days. Modern research shows Ashwagandha reduces cortisol levels, boosts mood, and aids neurogenesis - directly relevant to the stress-dysregulation and neurological damage of chronic addiction.
Brahmi (Bacopa monnieri): Brain tonic with documented antidepressant and anxiolytic effects. Brahmi calms Vata agitation, supports cognitive recovery, and reduces the depression and anxiety that dominate early recovery. Research confirms its ability to reduce cortisol levels and support neurogenesis alongside Panchakarma.
Guduchi (Tinospora cordifolia): Liver detoxification, immune restoration, and anti-inflammatory properties. Directly relevant given the hepatotoxicity of alcohol and the metabolic burden of many substances.
Jatamansi (Nardostachys jatamansi): A nerve relaxant and antidepressant. Addresses insomnia, anxiety, and emotional agitation during withdrawal and protracted abstinence. Used alongside Brahmi in classical Medhya formulations.

All herbal remedies must be prescribed and supervised by a qualified Ayurvedic practitioner, who will tailor the protocol to the individual’s constitution, drug history, and stage of recovery.

Yoga: Finding Harmony Within

Yoga addresses what neurochemistry alone cannot fully reach: the psychophysiological reset that chronic addiction has disrupted. Drug use, over time, dysregulates the autonomic nervous system – maintaining the body and nervous system in a state of chronic sympathetic activation (the stress response), with a corresponding reduction in parasympathetic tone (the rest-and-repair system). This manifests as hyperreactivity to triggers, difficulty sleeping, emotional dysregulation, and the chronic low-grade anxiety of early recovery. Yoga works from the body upward to reverse this.

The evidence base for yoga in substance use recovery has grown substantially. A 2024 article reviewing yoga and Ayurveda in substance abuse management cites multiple RCTs showing yoga reduces stress and craving in patients with substance use disorders. A PMC systematic review found yoga significantly reduces stress measures and negative mood in multiple controlled studies. The mechanisms include: elevated GABA (counteracting the GABA-deficiency state of alcohol and benzodiazepine withdrawal), increased serotonin and dopamine, HPA axis regulation, and vagal activation through pranayama.

Yoga for recovery: For Vata-pattern recovery (anxiety, restlessness, insomnia): grounding, slow, earthy practices - restorative yoga, Yin, Savasana, Yoga Nidra (yogic sleep). These activate the parasympathetic system and give the hyperactive nervous system a sustained experience of safety.
For Kapha-pattern recovery (heaviness, apathy, anhedonia): activating practices - Sun Salutations, standing sequences, Kapalabhati - that generate warmth, upward prana movement, and break through inertia.
For Pitta-pattern recovery (irritability, anger, craving intensity): cooling, non-competitive practices - forward folds, twists, Bhramari pranayama - that redirect emotional heat into structured physical channels.
Pranayama: Nadi Shodhana (alternate nostril breathing) for nervous system balance and HRV improvement. Bhramari (humming bee breath) for rapid vagal calming - directly useful in acute craving moments. Diaphragmatic belly breathing as a real-time craving management tool.
Meditation and mindfulness: Meditation and mindfulness practices, particularly Mindfulness-Based Relapse Prevention (MBRP) - adapted specifically for addiction recovery - teach the person to observe cravings as transient mental events rather than commands that must be obeyed. This is perhaps the most practically powerful skill in sustained recovery: surfing the craving rather than being overwhelmed by it.

Finding Your Path to Recovery: Treatment Options

Effective treatment for drug addiction does not pick one lever and pull it. It addresses the physical, psychological, social, and spiritual dimensions of recovery simultaneously – because addiction has embedded itself in all of those dimensions. The following is the evidence-based treatment landscape:

Medical Detoxification

Medically supervised detox manages withdrawal symptoms safely, prevents life-threatening complications (seizures in alcohol and benzodiazepine withdrawal; acute cardiovascular crises in stimulant withdrawal), and provides the clinical foundation on which the rest of treatment is built. Detox alone is not treatment – it is the first step. Rates of return to use after detox without ongoing treatment are extremely high.

Medication-Assisted Treatment (MAT)

MAT combines FDA-approved medications with behavioural therapies and is currently the gold standard for opioid and alcohol use disorders. NIDA Director Dr. Nora Volkow has stated that medications are irrefutably the most effective way to treat opioid use disorder, reducing the likelihood of overdose death by up to three-fold. According to NIDA (2023), MAT improves treatment retention rates by 70% and reduces the risk of opioid overdose deaths by up to 50%.

The three FDA-approved medications for opioid use disorder are:

Methadone: A full opioid agonist that binds opioid receptors slowly, preventing withdrawal and blocking craving without producing the rapid reward spike of shorter-acting opioids. Available only through federally regulated opioid treatment programmes. SAMHSA has confirmed that methadone decreases opioid-related deaths by over 50% when used consistently.
Buprenorphine (Suboxone): A partial opioid agonist (often combined with naloxone as Suboxone). It can be prescribed in office-based settings, dramatically improving access. Reduces withdrawal symptoms and craving without producing significant euphoria. The buprenorphine/naloxone combination is specifically formulated to discourage intravenous misuse - the naloxone component causes withdrawal if injected.
Naltrexone: An opioid antagonist that blocks the euphoric and sedative effects of opioids. Available as daily oral tablets or a monthly extended-release injection (Vivitrol). Most effective after full detoxification. Reduces cravings by eliminating the reinforcing effects of opioids if use occurs.

For alcohol use disorder, FDA-approved medications include naltrexone (also reduces alcohol craving), acamprosate (helps maintain abstinence by restoring GABA/glutamate balance post-detox), and disulfiram (creates aversive reactions to alcohol consumption to discourage relapse).

Psychotherapy

Medication addresses the physical and craving dimensions of addiction; therapy addresses the psychological rewiring. The key evidence-based approaches:

Cognitive Behavioural Therapy (CBT): The most extensively researched therapy for addiction. CBT helps the person identify the thoughts, emotions, and situational patterns that trigger use; restructures the cognitive distortions that maintain addiction ('I can't cope without it'; 'one won't hurt'); develops concrete coping skills for managing triggers and high-risk situations; and rebuilds the prefrontal executive function that addiction has eroded.
Dialectical Behaviour Therapy (DBT): Particularly valuable when addiction has co-occurred with emotional dysregulation, self-harm, or personality disorder. DBT builds four core skill sets: mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness - all of which directly counter the psychological vulnerabilities that sustain addiction.
Motivational Interviewing (MI): An empathic, collaborative approach that helps the person clarify their own reasons and motivation for change. Particularly useful in early-stage ambivalence about treatment and in addressing the shame and resistance that prevent people from engaging with care.
Mindfulness-Based Relapse Prevention (MBRP): Specifically adapted for addiction recovery, MBRP teaches the person to observe cravings, triggers, and high-risk states with mindful awareness - creating a gap between the craving signal and the automatic response to use. Multiple RCTs support its effectiveness for reducing relapse.
Support Groups and Peer Recovery: Provides accountability, peer connection, and lived-experience wisdom. 12-step programmes (NA, AA), SMART Recovery, and peer support groups all reduce isolation - one of the most powerful drivers of relapse - and provide ongoing recovery infrastructure beyond formal treatment.

Holistic and Integrative Therapies

Evidence-based holistic therapies complement clinical treatment and address dimensions of recovery that medication and talk therapy alone cannot fully reach: the nervous system’s chronic dysregulation, the need for embodied self-awareness, and the spiritual dimension of healing that many people in recovery identify as central to sustained sobriety. Yoga, meditation, Panchakarma, Ayurvedic herbal protocols, acupuncture, and mindfulness practices all have evidence bases relevant to addiction recovery when appropriately integrated alongside (not instead of) clinical treatment.

Recovery is a long game. NIDA defines addiction as a chronic, relapsing brain disease – with the same chronic management model as diabetes or hypertension. This is not pessimism; it is an accurate frame that sets realistic expectations. Most people in recovery need sustained support over months to years, not a single treatment episode. The goal is not just abstinence but the reconstruction of a life in which abstinence is supported: healthier relationships, meaningful activity, managed co-occurring conditions, and robust coping skills. This is achievable. Millions of people recover.

Story: Rajan's Journey

Rajan had built a life most people would not argue with. A successful architect at 42, two decades of work that he was genuinely proud of, a reputation in his field, a home he had designed himself. He was not someone who anyone would have looked at and thought: addiction risk.

The back injury happened on a construction site visit, the kind of thing that would sideline anyone for weeks. The painkillers his doctor prescribed were appropriate, effective, and exactly what was needed. For about six months. Then the pain changed – became less specific, more diffuse – and his relationship with the pills changed with it. He noticed, at a certain point, that he was not really managing pain anymore. He was managing the absence of the pills. The line between them, which had once seemed obvious, was now invisible.

He told himself this was still about the back. He was a disciplined man; he could stop whenever he chose. He chose, twice, and made it about four days each time before the physical reality of opioid withdrawal – the sweating, the muscle cramps, the catastrophic sleeplessness, the sensation that his skin was crawling inside out – sent him back to the prescription with the conviction that stopping this way was not possible. He was right about that part: unsupported opioid withdrawal rarely works for physical dependence of this magnitude. He was wrong about what it meant.

What he discovered in rehab, after a medically supported detox that managed the worst of the physical withdrawal with buprenorphine, was that the harder part was entirely in his mind. The body’s rebellion could be managed with medication. What could not be managed with medication was the craving that appeared every time he was under pressure at work, every time he sat in traffic for too long, every time he felt the particular anxiety of a difficult client meeting – the automatic, consuming pull of the one thing that had, for years, made those experiences bearable.

His therapist called it ‘the pharmaceutical escape hatch.’ Every time things had gotten hard over the past four years, Rajan had known the pills were there. They had not just relieved pain – they had relieved the psychological friction of being Rajan: the perfectionism, the chronic low-level performance anxiety, the difficulty ever fully switching off. The addiction had been, in part, a solution to a psychological problem that the pills had been conveniently treating. CBT, over several months, helped him see this pattern clearly enough to start working on the underlying problem rather than the symptom.

The yoga practice his rehab programme introduced he was sceptical of at first – he was not, he told his counsellor, a yoga person. What changed his mind was the pranayama. Specifically, Nadi Shodhana, which he learnt to use when he felt a craving spike during the day. The practice of five minutes of alternate nostril breathing in his car before a difficult meeting produced a measurable physiological shift – a settling of the nervous system that he could feel – and gave him a tool that worked in the real world, not just in therapy sessions.

The Ayurvedic practitioner who joined his recovery team identified a clear Vata-Pitta imbalance: the perfectionism and emotional intensity of Pitta feeding off the anxiety and nervous system overreactivity of aggravated Vata. Ashwagandha and Brahmi supplements, introduced under supervision, made a detectable difference to the background anxiety and cognitive fog of early recovery. Abhyanga became, to his surprise, something he looked forward to – a physical practice of self-care that was entirely unlike anything he had previously allowed himself.

Rajan is three years into recovery. He still sees his therapist monthly. He still practises pranayama before difficult meetings. He still tracks his stress levels and recognises when Vata has been climbing for a few days and he needs a more grounded evening. He does not describe himself as cured – he describes himself as having a much more honest and functional relationship with his own mind than he has had at any other point in his adult life. The pills gave him an escape hatch. Recovery gave him something better: the capacity to actually be where he is.

FAQs: Your Burning Questions Answered

Q: Is physical dependence the same as addiction?

Ans. No – and this distinction matters enormously. Physical dependence is a physiological adaptation that can occur with any drug taken regularly over time, including prescription medications taken exactly as directed. Your body adapts to the presence of the substance and adjusts withdrawal when it is removed. This is not addiction. Addiction – or Substance Use Disorder as the DSM-5 classifies it – requires the additional presence of compulsive drug-seeking and use despite harmful consequences, continued use despite genuine attempts to stop, and the reorganisation of the person’s life around obtaining and using the substance. Many people who are physically dependent on prescribed medications are not addicted. Many people who are addicted have both physical and psychological dependence. The clinical and human difference between the two matters enormously for how treatment is designed and how we talk about people in recovery.

Q: Can I overcome psychological dependence on my own?

Ans. Self-directed strategies – including mindfulness, exercise, social support, and structured routine – can be genuinely valuable tools in recovery. But for most people with moderate-to-severe addiction, professional support is not optional – it is the difference between a recovery that holds and one that cycles through repeated relapse. Psychological dependence involves neurological changes (weakened PFC function, hyperactive stress reactivity, consolidated drug-memory circuits) and often co-occurring mental health conditions that require clinical assessment and treatment to address. CBT, DBT, motivational interviewing, and MBRP are not luxury extras – they are empirically validated interventions that produce measurable changes in the brain processes sustaining addiction. SAMHSA’s National Helpline (1-800-662-HELP / 1-800-662-4357) is available 24/7, free, and confidential, and can connect you with treatment options.

Q: What role does trauma play in addiction?

Ans. A very significant one. Research consistently documents that adverse childhood experiences (ACEs), trauma, and PTSD substantially increase the risk of developing substance use disorders. The connection is both psychological (using substances to manage traumatic stress, hyperarousal, intrusive memories, and emotional numbing) and neurobiological (trauma disrupts the same HPA axis stress systems and prefrontal-limbic circuits that addiction also dysregulates). Treating addiction without addressing co-occurring trauma is one of the most common reasons treatment fails. Evidence-based trauma therapies – particularly Trauma-Focused CBT and EMDR (Eye Movement Desensitisation and Reprocessing) – are important components of integrated addiction and trauma treatment. SAMHSA estimates that over two-thirds of people in addiction treatment have a history of trauma.

Q: How long does recovery take?

Ans. Recovery is better understood as an ongoing process than a destination with a finish line – which is what NIDA’s framing of addiction as a chronic condition reflects. The acute phase (detox and early treatment) typically lasts weeks to months. The sustained recovery phase – during which the neurological and psychological changes of addiction are progressively being reversed and new habits, relationships, and coping skills are being built – extends over years. Most clinical guidelines recommend a minimum of 12 months of sustained engagement with treatment and recovery support after initial stabilisation. Longer is generally better, particularly for people with severe addiction, long duration of use, multiple substances, or co-occurring mental health conditions. This is not a reason for despair – it is an accurate map of what the recovery journey actually looks like. And millions of people complete it successfully.

Conclusion

The tug-of-war between mind and body in addiction is not a metaphor. It is a precise description of two neurobiological systems – the reward circuitry and the stress circuitry – operating in chronic dysregulation, each one pulling in the direction of use. Understanding this is not just intellectually interesting. It is clinically actionable: it tells us why detox alone almost never produces lasting recovery, why medication is not replacing one addiction with another but normalising a dysregulated brain, why psychological therapy is not optional support but a core treatment modality, and why integrated care that addresses all dimensions of recovery – physical, psychological, and spiritual – consistently produces better outcomes than any single approach in isolation.

If you or someone you care about is struggling with addiction, please know that effective help exists, that recovery is possible regardless of how long the addiction has lasted or how many previous attempts have failed, and that asking for help is the most practical and courageous thing to do next.

SAMHSA’s National Helpline is available 24 hours a day, 7 days a week, completely free and confidential: call or text 1-800-662-4357 (1-800-662-HELP). It provides referrals to local treatment centres, support groups, and community-based organisations. You do not need insurance to call. You do not need to know what you are looking for. You just need to make the call.

Relationships

Navigating Life

About Us